共 72 条
[1]
Guan WJ(2020)Clinical characteristics of coronavirus disease 2019 in China N Engl J Med 382 1708-1720
[2]
Ni ZY(2020)Weathering the cytokine storm in COVID-19: therapeutic implications Cardiorenal Med 10 277-287
[3]
Hu Y(2019)SARS-Coronavirus Open Reading Frame-8b triggers intracellular stress pathways and activates NLRP3 inflammasomes Cell Death Discov 5 101-1280
[4]
Liang WH(2020)Targeting the NLRP3 inflammasome in severe COVID-19 Front Immunol 11 1518-e121
[5]
Ou CQ(2020)Interleukin-1 and the inflammasome as therapeutic targets in cardiovascular disease Circ Res 126 1260-e331
[6]
He JX(2014)Formation of the inflammasome in acute myocarditis Int J Cardiol 171 e119-18953
[7]
Iannaccone G(2019)Inflammasome formation in granulomas in cardiac sarcoidosis Circ Arrhythm Electrophysiol 12 e007582-458
[8]
Scacciavillani R(2020)SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor Cell 181 e8-undefined
[9]
Del Buono MG(2020)Interleukin-1 blockade with high-dose anakinra in patients with COVID-19, acute respiratory distress syndrome, and hyperinflammation: a retrospective cohort study Lancet Rheumatol 2 e325-undefined
[10]
Camilli M(2020)Early IL-1 receptor blockade in severe inflammatory respiratory failure complicating COVID-19 Proc Natl Acad Sci USA 117 18951-undefined